X

Pfizer Limited Q3FY23 Earnings Story

Pfizer Ltd is primarily involved in marketing, exporting, manufacturing, and trading of pharmaceutical products. It produces goods through its in-house facility and also works with numerous independent contract and third-party manufacturers located all throughout the nation. It sells its goods through independent distributors, primarily in India.

Financial Results:

During the period ended December 31, 2022, the company reported a total income of INR 649.16 crores. This is in comparison to INR 694. 16 crores that was reported in the period ended December 31, 2021.

As against the net profit / (loss) of INR 143.91 crores for the period ended December 31, 2021, the company reported a net profit / (loss) of INR150.66 crores for the period ended December 31, 2022.

For the period ended December 31, 2022, the Earnings Per Share of the company was reported to be INR 32.93. This is in comparison to the EPS of the company which was at INR 31.46 for the period ended December 31, 2021.

Related Post